Skip to main content
. 2022 Oct 12;13:944452. doi: 10.3389/fimmu.2022.944452

Figure 2.

Figure 2

Heatmap showing the global landscape of glioblastoma (GBM) immunotherapies including; immunocheckpont inhibitors (ICI), Oncolytic virotherapy (OV), Non-replicating viral vectors (NRVV), CAR-T cell therapy (CAR). The number of GBM immunotherapies clinical trials are expressed on the country level. Data is extracted from clinicaltrials.gov/.